Alterations in the TIF1-γ gene have been described in cancer cells from patients with CAM, possibly representing the neo-self and thus triggering the anti-cancer immune response, which can culminate in autoimmunity to native TIF1-γ antigens (48). This evidence concerns the gene TRIM33 and cancer.